v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Condensed Consolidated Statements of Operations and Comprehensive Loss    
License Revenue $ 300  
Operating Costs and Expenses:    
General and administrative 2,072 $ 1,449
Research and development 355 2,968
Total Operating Costs and Expenses 2,427 4,417
Loss from Operations (2,127) (4,417)
Other Income:    
Foreign currency exchange (loss) gain 1 (3)
Interest income 82 96
Total Other Income 83 93
Net Loss before income taxes (2,044) (4,324)
Net Loss Attributable to Common Stockholders $ (2,044) $ (4,324)
Net Loss Per Share - Basic (in dollars per share) $ (0.05) $ (1.55)
Net Loss Per Share - Dilutive (in dollars per share) $ (0.05) $ (1.55)
Weighted average number of shares outstanding during the period - Basic (in shares) 41,072,725 2,782,449
Weighted average number of shares outstanding during the period - Dilutive (in shares) 41,072,725 2,782,449
Net Loss $ (2,044) $ (4,324)
Gain (loss) on foreign currency translation (378) 654
Total comprehensive loss $ (2,422) $ (3,670)